Related Experiment Video
Updated: Aug 20, 2026

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
[Evolution of tobacco habits during pregnancy and postpartum period]
Jf Doz Mora1, G Gasulla Pascual, S Cárceles Jurado
1CAP Badia del Vallès, Badia del Vallès, Barcelona, España. 22414fdm@comb.es
Objective:
To describe how smoking evolved during pregnancy and a long postpartum period, with analysis of the factors associated with giving up tobacco.
Design:
Retrospective, descriptive study.
Setting:
Badia del Vallès Primary Care Centre (Barcelona).
Participants:
Women with pregnancies coming to term over a 3-year period (n=309, 68% of the target population).
Main Measurements:
Tobacco dependency before pregnancy. Giving up during pregnancy and related factors (social and personal, nature of tobacco habit, health beliefs). Backsliding after birth.
Results:
50% smoked before pregnancy. 46% of these gave up smoking during pregnancy and 44% cut down. In primigravidae, there was greater risk of their continuing to smoke, the greater their previous tobacco consumption was (OR=5.3 if > or =20 cigarettes a day and OR=4.7 for 10-19 cigarettes a day) or if they did not believe in the effect of tobacco on the baby's health (OR=3.9). In women pregnant for the second time or more, it was associated with not giving up tobacco in previous pregnancies (OR=43.8) and with their partner's tobacco habit (OR=7.2). In the 2 years after birth 80% of those who gave up relapsed.
Conclusions:
In our milieu a high prevalence of smokers before pregnancy coexists with a high rate of giving up during pregnancy. In all, 1 in every 4 women smokes during pregnancy. Giving up tobacco was related to factors such as dependency, motivation, environment and prior experience.
Related Concept Videos
Development of the Oral Microbiota
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Oogenesis
Stress Prevention and Stress Management Techniques IV
Development of Human Microbiota
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
